Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Soverini

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Journal of Cancer Research and Clinical Oncology|November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phaseKaterina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Leukemia|July 30, 2022
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemiaSimona Soverini, Sara De Santis, Margherita Martelli, et al.
Journal of Hematology & Oncology|December 6, 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paperSimona Soverini, Elisabetta Abruzzese, Monica Bocchia, et al.
Cancer Research|October 21, 2010
Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemiaMarco Della Peruta, Giovanni Martinelli, Elisabetta Moratti, et al.
Molecular Cancer Research : MCR|June 23, 2011
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cellsAntonio Porro, Nunzio Iraci, Simona Soverini, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Leukemia Research|March 18, 2014
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete responseIlaria Iacobucci, Annalisa Lonetti, Claudia Venturi, et al.
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Journal of Cancer Research and Clinical Oncology|November 5, 2014
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phaseKaterina Machova Polakova, Vojtech Kulvait, Adela Benesova, et al.
Biomarker Research|March 9, 2023
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targetedManuela Mancini, Cecilia Monaldi, Sara De Santis, et al.
Leukemia|July 30, 2022
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemiaSimona Soverini, Sara De Santis, Margherita Martelli, et al.
Journal of Hematology & Oncology|December 6, 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paperSimona Soverini, Elisabetta Abruzzese, Monica Bocchia, et al.
Cancer Research|October 21, 2010
Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemiaMarco Della Peruta, Giovanni Martinelli, Elisabetta Moratti, et al.
Molecular Cancer Research : MCR|June 23, 2011
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cellsAntonio Porro, Nunzio Iraci, Simona Soverini, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Leukemia Research|March 18, 2014
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete responseIlaria Iacobucci, Annalisa Lonetti, Claudia Venturi, et al.
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Leukemia|October 4, 2023
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemiaNicholas C P Cross, Thomas Ernst, Susan Branford, et al.
Pageof 17